ProCure Proton Therapy Center marks its 13th anniversary this March, celebrating a legacy of state-of-the-art technology with a patient-centered approach in cancer care. Since 2012, ProCure has helped ...

Every year, aggressive forms of cancer are occurring in more young adults. Circle of Health reporter Denise Dador brings you ...

A York County business owner is sharing his story of hope after completing an innovative cancer treatment at WellSpan York Hospital. John Grim has been battling prostate cancer for nearly seven years, ...

Chinese-based Innovent Biologics and HUTCHMED are eyeing approval for their cancer combination after a joint Phase II/III ...

The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...

Of these, more than 4.5 lakh treatments worth over Rs 985 crore were undertaken for "targeted therapies" against cancer, with ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

US cancer patients have reported positive and negative experiences when sharing patient-identified information with their health care providers.

Researchers at UC San Diego have developed advanced deep learning techniques that could revolutionize treatment planning for ...

Dr. Moghanaki joins a prestigious board of lung cancer experts committed to attracting top researchers to the field of lung ...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

Advances in medicine mean more kids than ever beat cancer, but that’s just the beginning. Many childhood cancer survivors face long-term health challenges caused by the very treatments that saved them ...